急性肠系膜缺血开放血运重建与血管内介入相比发病率和死亡率增加
基于NSQIP数据库2011至2022年1172例急性肠系膜缺血患者(开放1023例、血管内149例),在校正肠切除需求和合并症后,开放手术组30天死亡率(OR 1.96,95%CI 1.28-3.02)、脱机失败(OR 1.56,95%CI 1.05-2.34)和住院时间(β 3.7天,95%CI 1.8-5.6)均高于血管内介入组。
要点
- 开放组30天死亡率校正后高于血管内组(OR 1.96,95%CI 1.28-3.02)。
- 开放组脱机失败风险更高(OR 1.56,95%CI 1.05-2.34)。
- 开放组住院时间更长(β 3.7天,95%CI 1.8-5.6)。
核心结论
- 在校正肠切除需求和合并症后,开放血运重建与更高的围手术期发病率和死亡率相关,肠切除需求不应排除血管内治疗。
研究设计与样本
- 回顾性队列研究,利用NSQIP数据库识别2011至2022年因急性肠系膜缺血接受血运重建的患者,按CPT代码分为开放组(1023例)和血管内组(149例)。
主要发现
- 血管内组吸烟比例更高(开放36% vs 血管内47%,P<0.01),eGFR低于30比例更高(开放6% vs 血管内15%,P<0.01),初次手术时肠切除比例更高(开放33% vs 血管内48%,P<0.01)。
- 开放组中位住院时间更长(10天 vs 7天,P<0.01),单变量分析中包括30天死亡率在内的其他结局相似。
- 校正肠切除需求和合并症后,开放组30天死亡率(OR 1.96,95%CI 1.28-3.02)、脱机失败(OR 1.56,95%CI 1.05-2.34)和住院时间(β 3.7天,95%CI 1.8-5.6)更高。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Historically, open approaches have been considered the primary treatment for acute mesenteric ischemia (AMI) due to the potential for bowel resection. However, the use of endovascular therapy is increasing. Given the paucity of current data, this study aims to compare outcomes between open and endovascular interventions for AMI. METHODS: Patients treated for AMI between 2011 and 2022 were identified in the National Surgical Quality Improvement Program (NSQIP) by ICD-9 and ICD-10 codes. Intervention type (open vs. endovascular) was obtained from CPT codes. Demographics, comorbidities, pre-operative laboratory values, and 30-day outcomes were compared between intervention types. Multivariable analysis was utilized to adjust for differences between groups with a patient's need for bowel resection included to account for disease severity. RESULTS: A total of 1,172 patients underwent revascularization for AMI (1,023 open, 149 endovascular). Among those treated with open revascularization, 577 (56%) underwent thrombectomies/embolectomy, 125 (12%) underwent thromboendarterectomy, and 321 (31%) received bypasses. Of the patients who underwent endovascular revascularizations, 101 (68%) received a stent, 23 (15%) underwent angioplasty without stenting, and 25 (17%) underwent lysis/thrombectomy. Patients who underwent endovascular revascularization had higher rates of smoking (36% open vs. 47% endovascular; P < 0.01), were more likely to have an eGFR less than 30 (6% open vs. 15% endovascular; P < 0.01), and underwent more bowel resections at the time of the initial operation (33% open vs. 48% endovascular; P < 0.01). For outcomes, patients who underwent open repair had longer median hospital stays (10 days vs. 7 days; P < 0.01). All other outcomes including 30-day mortality were similar on univariate analysis. Following adjustment for the need for bowel resection and comorbidities, 30-day-mortality (OR 1.96, 95% CI: 1.28-3.02), failure to wean from ventilator (OR 1.56 95% CI: 1.05-2.34), and length of hospital stay (β 3.7 days, 95% CI: 1.8-5.6) were higher among patients treated with open surgery. CONCLUSIONS: After accounting for the need for bowel resection and comorbidities, open revascularization for AMI is associated with higher peri-operative morbidity and mortality compared to endovascular intervention. Thus, the need for bowel resection should not preclude endovascular treatment for AMI.
引用
- Warren AS, Murphy B, Saldana-Ruiz N, et al. Open Revascularization for Acute Mesenteric Ischemia is Associated with Increased Morbidity and Mortality when Compared to Endovascular Intervention. Ann Vasc Surg. 2024. PMID: 39580026. doi:10.1016/j.avsg.2024.10.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。